Abstract
Endoscopic therapies targeting pancreatic neuroendocrine tumors (PNETs) are not considered standard of care. This is especially true for patients with localized and potentially curable disease. On the other hand, endoscopic guided therapies, to debulk the tumor and/or to control symptoms, have been offered to patients with either metastatic disease or those who are poor surgical candidates. Various endoscopic ultrasound (EUS)-guided local ablation therapies such as radiofrequency ablation, photodynamic therapy, and brachytherapy are some of the other modalities that have been evaluated or are under investigation for the treatment of PNETs. EUS has also been used to deliver fiducials within or adjacent to small PNETs to facilitate visualization of these small lesions at the time of parenchymal-sparing pancreatic surgery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jurgensen C, Schuppan D, Neser F, et al. EUS-guided alcohol ablation of an insulinoma. Gastrointest Endosc. 2006;63:1059–62.
Seo DW. EUS-guided antitumor therapy for pancreatic tumors. Gut Liver. 2010;4 Suppl 1:S76–81.
Gaidhane M, Smith I, Ellen K, et al. Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) of the pancreas in a porcine model. Gastroenterol Res Pract. 2012;2012:431451.
Scott A, Hinwood D, Donnelly R. Radio-frequency ablation for symptom control in a patient with metastatic pancreatic insulinoma. Clin Endocrinol (Oxf). 2002;56:557–9.
Varas MJ, Gornals JB, Pons C, et al. Usefulness of endoscopic ultrasonography (EUS) for selecting carcinoid tumors as candidates to endoscopic resection. Rev Esp Enferm Dig. 2010;102:577–82.
Law JK, Singh VK, Khashab MA, et al. Endoscopic ultrasound (EUS)-guided fiducial placement allows localization of small neuroendocrine tumors during parenchymal-sparing pancreatic surgery. Surg Endosc. 2013;27:3921–6.
Chen WF, Zhou PH, Li QL, et al. Clinical impact of endoscopic submucosal dissection for gastric neuroendocrine tumors: a retrospective study from mainland of China. Scientific World J. 2012;2012:869769.
Gomez V, Groce JR, Xaio SY, et al. Band ligation resection of duodenal carcinoid (with video). Gastrointest Endosc. 2007;66:397. discussion 398.
Metz DC, Jensen RT. Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. Gastroenterology. 2008;135:1469–92.
Frilling A, Akerstrom G, Falconi M, et al. Neuroendocrine tumor disease: an evolving landscape. Endocr Relat Cancer. 2012;19:R163–85.
Imamura M, Komoto I, Ota S, et al. Biochemically curative surgery for gastrinoma in multiple endocrine neoplasia type 1 patients. World J Gastroenterol. 2011;17:1343–53.
Thakker RV, Newey PJ, Walls GV, et al. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab. 2012;97:2990–3011.
Scherubl H, Jensen RT, Cadiot G, et al. Management of early gastrointestinal neuroendocrine neoplasms. World J Gastrointest Endosc. 2011;3:133–9.
Dalenback J, Havel G. Local endoscopic removal of duodenal carcinoid tumors. Endoscopy. 2004;36:651–5.
Lee SH, Hong YS, Lee JM, et al. Duodenal gastrinoma treated with endoscopic band ligation. Gastrointest Endosc. 2009;69:964–7.
Milan SA, Yeo CJ. Neuroendocrine tumors of the pancreas. Curr Opin Oncol. 2012;24:46–55.
DiNorcia J, Lee MK, Reavey PL, et al. One hundred thirty resections for pancreatic neuroendocrine tumor: evaluating the impact of minimally invasive and parenchyma-sparing techniques. J Gastrointest Surg. 2010;14:1536–46.
Goldberg SN, Mallery S, Gazelle GS, et al. EUS-guided radiofrequency ablation in the pancreas: results in a porcine model. Gastrointest Endosc. 1999;50:392–401.
Kim HJ, Seo DW, Hassanuddin A, et al. EUS-guided radiofrequency ablation of the porcine pancreas. Gastrointest Endosc. 2012;76:1039–43.
Wu PH, Pan CC, Huang ZL, et al. Percutaneous radiofrequency ablation approach through the spleen: initial case report for pancreatic tail gastrinoma. Chin J Cancer. 2010;29:836–41.
Deprez PH, Claessens A, Borbath I, et al. Successful endoscopic ultrasound-guided ethanol ablation of a sporadic insulinoma. Acta Gastroenterol Belg. 2008;71:333–7.
DiMaio CJ, DeWitt JM, Brugge WR. Ablation of pancreatic cystic lesions: the use of multiple endoscopic ultrasound-guided ethanol lavage sessions. Pancreas. 2011;40:664–8.
DeWitt J, DiMaio CJ, Brugge WR. Long-term follow-up of pancreatic cysts that resolve radiologically after EUS-guided ethanol ablation. Gastrointest Endosc. 2010;72:862–6.
Marques I, Ribeiro MD, Pimentel-Nunes P, et al. Endoscopic submucosal dissection of solitary duodenal somatostatinoma (with video). Gastrointest Endosc. 2012;76:693–4.
Norton JA, Melcher ML, Gibril F, et al. Gastric carcinoid tumors in multiple endocrine neoplasia-1 patients with Zollinger-Ellison syndrome can be symptomatic, demonstrate aggressive growth, and require surgical treatment. Surgery. 2004;136:1267–74.
Nikou GC, Angelopoulos TP. Current concepts on gastric carcinoid tumors. Gastroenterol Res Pract. 2012;2012:287825.
Hoffmann KM, Furukawa M, Jensen RT. Duodenal neuroendocrine tumors: classification, functional syndromes, diagnosis and medical treatment. Best Pract Res. 2005;19:675–97.
Witzigmann HLC, Geissler F, et al. Neuroendocrine tumours of the duodenum. Clinical aspects, pathomorphology and therapy. Langenbecks Arch Surg. 2002;386:525–33.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Raina, A., Chandrasekhara, V. (2015). Endoscopic Approaches to Treatment of Pancreatic Neuroendocrine Neoplasms. In: Pisegna, J. (eds) Management of Pancreatic Neuroendocrine Tumors. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1798-3_8
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1798-3_8
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1797-6
Online ISBN: 978-1-4939-1798-3
eBook Packages: MedicineMedicine (R0)